61 related articles for article (PubMed ID: 19999547)
21. Loss of the cyclin-dependent kinase inhibitor p27(Kip1) protein in human prostate cancer correlates with tumor grade.
Guo Y; Sklar GN; Borkowski A; Kyprianou N
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2269-74. PubMed ID: 9815624
[TBL] [Abstract][Full Text] [Related]
22. Expression of androgen receptor and growth factors in premalignant lesions of the prostate.
Harper ME; Glynne-Jones E; Goddard L; Mathews P; Nicholson RI
J Pathol; 1998 Oct; 186(2):169-77. PubMed ID: 9924433
[TBL] [Abstract][Full Text] [Related]
23. Number and location of nucleoli and presence of apoptotic bodies in diagnostically challenging cases of prostate adenocarcinoma on needle biopsy.
Aydin H; Zhou M; Herawi M; Epstein JI
Hum Pathol; 2005 Nov; 36(11):1172-7. PubMed ID: 16260270
[TBL] [Abstract][Full Text] [Related]
24. Decreased NKX3.1 protein expression in focal prostatic atrophy, prostatic intraepithelial neoplasia, and adenocarcinoma: association with gleason score and chromosome 8p deletion.
Bethel CR; Faith D; Li X; Guan B; Hicks JL; Lan F; Jenkins RB; Bieberich CJ; De Marzo AM
Cancer Res; 2006 Nov; 66(22):10683-90. PubMed ID: 17108105
[TBL] [Abstract][Full Text] [Related]
25. Clinical significance of high-grade prostatic intraepithelial neoplasia in transurethral resection specimens.
Pacelli A; Bostwick DG
Urology; 1997 Sep; 50(3):355-9. PubMed ID: 9301697
[TBL] [Abstract][Full Text] [Related]
26. Up-regulation of insulin-like growth factor axis components in human primary prostate cancer correlates with tumor grade.
Liao Y; Abel U; Grobholz R; Hermani A; Trojan L; Angel P; Mayer D
Hum Pathol; 2005 Nov; 36(11):1186-96. PubMed ID: 16260272
[TBL] [Abstract][Full Text] [Related]
27. Production of serum-free and total prostate-specific antigen due to prostatic intraepithelial neoplasia.
Minardi D; Galosi AB; Dell'Atti L; Hanitzsch H; Mario P; Muzzonigro G
Scand J Urol Nephrol; 2002; 36(5):323-9. PubMed ID: 12487735
[TBL] [Abstract][Full Text] [Related]
28. Prohibitin and cofilin are intracellular effectors of transforming growth factor beta signaling in human prostate cancer cells.
Zhu B; Fukada K; Zhu H; Kyprianou N
Cancer Res; 2006 Sep; 66(17):8640-7. PubMed ID: 16951178
[TBL] [Abstract][Full Text] [Related]
29. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.
Zhu ML; Partin JV; Bruckheimer EM; Strup SE; Kyprianou N
Prostate; 2008 Feb; 68(3):287-95. PubMed ID: 18163430
[TBL] [Abstract][Full Text] [Related]
30. Upregulation of erythropoietin receptor in human prostate carcinoma and high-grade prostatic intraepithelial neoplasia.
Zhou T; Xu C; He M; Sun Y
Prostate Cancer Prostatic Dis; 2008; 11(2):143-7. PubMed ID: 17637760
[TBL] [Abstract][Full Text] [Related]
31. Significance of apoptosis in prostatic intraepithelial neoplasia and carcinoma.
Sherwani R; Khan S; Khan N; Kamran M; Husain M
Indian J Pathol Microbiol; 2005 Oct; 48(4):444-7. PubMed ID: 16366091
[TBL] [Abstract][Full Text] [Related]
32. High-grade prostatic intraepithelial neoplasialike ductal adenocarcinoma of the prostate: a clinicopathologic study of 28 cases.
Tavora F; Epstein JI
Am J Surg Pathol; 2008 Jul; 32(7):1060-7. PubMed ID: 18496142
[TBL] [Abstract][Full Text] [Related]
33. High-grade prostatic intraepithelial neoplasia with adjacent small atypical glands on prostate biopsy.
Kronz JD; Shaikh AA; Epstein JI
Hum Pathol; 2001 Apr; 32(4):389-95. PubMed ID: 11331955
[TBL] [Abstract][Full Text] [Related]
34. Progressive increase of apoptosis in prostatic intraepithelial neoplasia and carcinoma: comparison between in situ end-labeling of fragmented DNA and detection by routine hematoxylin-eosin staining.
Drachenberg CB; Ioffe OB; Papadimitriou JC
Arch Pathol Lab Med; 1997 Jan; 121(1):54-8. PubMed ID: 9111093
[TBL] [Abstract][Full Text] [Related]
35. Precursors of prostatic cancer: progression, regression and chemoprevention.
Montironi R; Schulman CC
Eur Urol; 1996; 30(2):133-7. PubMed ID: 8875193
[No Abstract] [Full Text] [Related]
36. Prostatic adenocarcinoma. Carcinogenesis and growth.
Moon TD; Sloane BB
J Am Geriatr Soc; 1989 Jan; 37(1):55-64. PubMed ID: 2642500
[No Abstract] [Full Text] [Related]
37. Pain management as a legal responsibility.
Weiler K
J Gerontol Nurs; 1992 Oct; 18(10):46. PubMed ID: 1479158
[No Abstract] [Full Text] [Related]
38. Malignant changes in the prostate with ageing.
Dunsmuir WD; Hrouda D; Kirby RS
Br J Urol; 1998 Dec; 82 Suppl 1():47-58. PubMed ID: 9883262
[No Abstract] [Full Text] [Related]
39. [Apoptosis in pathologic prostatic processes].
Kruslin B
Acta Med Croatica; 2009 Oct; 63 Suppl 2():49-52. PubMed ID: 19999547
[TBL] [Abstract][Full Text] [Related]
40. Apoptotic regulators in prostatic intraepithelial neoplasia (PIN): value in prostate cancer detection and prevention.
Zeng L; Kyprianou N
Prostate Cancer Prostatic Dis; 2005; 8(1):7-13. PubMed ID: 15477876
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
